Surrozen's Insider Selling: A $7 Million Red Flag Amidst Biotech Optimism

Related Articles

Is Flex's Recent Insider Selling a Red Flag for Investors

6 months ago

Natera's Insider Selling Spree: A Red Flag Amidst Robust Growth

4 months ago

Is Recent Insider Selling a Red Flag for PAR Technology

8 months ago

Remitly's Insider Exodus: A Red Flag Amidst Record Highs

3 months ago

Category

You may also like

Stock News•2 weeks ago

Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million

Surrozen closed the second and final tranche of its March 2025 private placement, raising $95.1M total. The capital extends the company's runway to advance its Wnt-signaling ophthalmic programs.

SRZN

Share

Stock News•3 months ago

After a 96% 1-Year Run, This Director Sold 37,600 PHVS Shares for $1.3 Million. Is the Rally Over?

PHVS director sold 37,600 shares for $1.3 million after a 96% one-year rally. Insider selling at a rare-disease biotech may signal caution near current levels.

PHVS

Share

Stock News•4 months ago

What This Immunome Sale Means a Day Before a Big FDA Milestone

An Immunome insider sold 100K shares (~$2.4M) on July 6-7, 2026, representing 32% of their holdings, ahead of a major FDA milestone.

IMNM

Share